Limei Shen
- Immunology top 5%
- Biomedical Engineering top 5%
- Molecular Biology
- Oncology top 5%
- Biomaterials top 5%
- Co-authors
- Leaf HuangWantong SongRihe LiuTyler J. GoodwinXueqiong ZhangYun LiuYing WangLin Hou
- Topics
- Immunotherapy and Immune Responses (13 papers)Cancer Immunotherapy and Biomarkers (10 papers)Immune Cell Function and Interaction (6 papers)
- Cited by
- ImmunologyBiomaterialsOncology
- Partner nations
- United StatesChinaGermany
In The Last Decade
Limei Shen
39 papers receiving 2.0k citations
Hit Papers
Peers
Comparison fields: 5 of 107
- Immunology 867
- Biomedical Engineering 667
- Molecular Biology 600
- Oncology 597
- Biomaterials 388
Countries citing papers authored by Limei Shen
This map shows the geographic impact of Limei Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Limei Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Limei Shen more than expected).
Fields of papers citing papers by Limei Shen
This network shows the impact of papers produced by Limei Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Limei Shen. The network helps show where Limei Shen may publish in the future.
Co-authorship network of co-authors of Limei Shen
This figure shows the co-authorship network connecting the top 25 collaborators of Limei Shen. A scholar is included among the top collaborators of Limei Shen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Limei Shen. Limei Shen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 3 | |
| 3 | 14 | |
| 4 | 1 | |
| 5 | 2 | |
| 6 | 17 | |
| 7 | 12 | |
| 8 | 49 | |
| 9 | 36 | |
| 10 | 77 | |
| 11 | 42 | |
| 12 | 3 | |
| 13 | 79 | |
| 14 | Synergistic and low adverse effect cancer immunotherapy by immunogenic chemotherapy and locally expressed PD-L1 trapbreakdown → | 345 |
| 15 | 77 | |
| 16 | 20 | |
| 17 | 22 | |
| 18 | 7 | |
| 19 | 40 | |
| 20 | 97 |
About Limei Shen
Limei Shen is a scholar working on Immunology, Oncology and Immunology and Allergy, having authored 39 papers that have together received 2.0k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (13 papers), Cancer Immunotherapy and Biomarkers (10 papers) and Immune Cell Function and Interaction (6 papers). The work is most often cited by research in Immunology (867 citations), Biomaterials (388 citations) and Oncology (597 citations). Limei Shen has collaborated with scholars based in United States, China and Germany. Frequent co-authors include Leaf Huang, Wantong Song, Rihe Liu, Tyler J. Goodwin, Xueqiong Zhang, Yun Liu, Ying Wang, Lin Hou, Qi Liu and Fengqian Chen. Their work appears in journals such as Advanced Materials, Nature Communications and ACS Nano.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.